Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
Abstract We aimed to evaluate the effect of baseline low-density lipoprotein cholesterol (LDL-C) on the outcomes of patients with the acute coronary syndrome (ACS) receiving pitavastatin monotherapy or the combination of pitavastatin + ezetimibe. In the HIJ-PROPER study, 1734 ACS patients with dysli...
Saved in:
Main Authors: | Jihaeng Im, Erisa Kawada-Watanabe, Junichi Yamaguchi, Hiroyuki Arashi, Hisao Otsuki, Yuko Matsui, Haruki Sekiguchi, Shinya Fujii, Fumiaki Mori, Hiroshi Ogawa, Nobuhisa Hagiwara |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/55e0b3b526d3450e93a0b58908acb01c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals
by: Shogo Matsui, et al.
Published: (2017) -
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
by: Yu-Cheng Kao, et al.
Published: (2021) -
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
by: Chandni Bardolia, et al.
Published: (2021) -
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
by: Yi-Heng Li, et al.
Published: (2020) -
Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
by: Rej S, et al.
Published: (2016)